Spurdle AB, Healey S, Devereau A, Hogervorst FB, Monteiro AN, Nathanson KL, Radice P, Stoppa-Lyonnet D, Tavtigian S, Wappenschmidt B et al. ENIGMA--evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes. Human Mutation. 2012 Jan;33(1):2-7. doi: 10.1002/humu.21628. Epub 2011 Nov 3.
Wong EM, Southey MC, Fox SB, Brown MA, Dowty JG, Jenkins MA, Giles GG, Hopper JL, Dobrovic A. Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer. Cancer Prevention Research (Philadelphia, Pa). 2011 Jan;4(1):23-33.
Smith LD, Tesoriero AA, Wong EM, Ramus SJ, O'Malley FP, Mulligan AM, Terry MB, Senie RT, Santella RM, John EM et al. Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry. Breast Cancer Research. 2011 Jan 13(1): R14.
Park DJ, Southey MC, Giles GG, Hopper JL. No evidence of MMTV-like env sequences in specimens from the Australian Breast Cancer Family Study. Breast Cancer Research and Treatment. 2011 Jan;125(1):229-235.
Schrader KA, Masciari S, Boyd N, Salamanca C, Senz J, Saunders DN, Yorida E, Maines-Bandiera S, Kaurah P, Tung N et al. Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers. Journal of Medical Genetics. 2011 Jan;48(1):64-68.
Le Calvez-Kelm F, Lesueur F, Damiola F, Vallee M, Voegele C, Babikyan D, Durand G, Forey N, McKay-Chopin S, Robinot N et al. Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study. Breast Cancer Research. 2011 Jan 13(1):R6.
van Vliet CM, Dowty JG, van Vliet JL, Smith L, Mead LJ, Macrae FA, St John DJ, Giles GG, Southey MC, Jenkins MA et al. Dependence of colorectal cancer risk on the parent-of-origin of mutations in DNA mismatch repair genes. Human Mutation. 2011 Feb;32(2):207-212.
Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, Gaudet M, Schmidt MK, Broeks A, Cox A et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. Journal of the National Cancer Institute. 2011 Feb 2;103(3):250-263.
Southey MC, Ramus SJ, Dowty JG, Smith LD, Tesoriero AA, Wong EE, Dite GS, Jenkins MA, Byrnes GB, Winship I et al. Morphological predictors of BRCA1 germline mutations in young women with breast cancer. British Journal of Cancer. 2011 Mar 15;104(6):903-909.
Lindstrom S, Vachon CM, Li J, Varghese J, Thompson D, Warren R, Brown J, Leyland J, Audley T, Wareham NJ et al. Common variants in ZNF365 are associated with both mammographic density and breast cancer risk. Nature Genetics. 2011 Mar;43(3):185-187.
Win AK, Dowty JG, Antill YC, English DR, Baron JA, Young JP, Giles GG, Southey MC, Winship I, Lipton L et al. Body mass index in early adulthood and endometrial cancer risk for mismatch repair gene mutation carriers. British Journal of Cancer. 2011 Jun 28;105(1):162-9.
Martrat G, Maxwell CM, Tominaga E, Porta-de-la-Riva M, Bonifaci N, Gomez-Baldo L, Bogliolo M, Lazaro C, Blanco I, Brunet J et al. Exploring the link between MORF4L1 and risk of breast cancer. Breast Cancer Research. 2011 Apr 13(2).
Bertalli NA, Allen KJ, McLaren CE, Turkovic L, Osborne NJ, Constantine CC, Delatycki MB, English DR, Giles GG, Hopper JL et al. A comparison of self-reported and record-linked blood donation history in an Australian cohort. Transfusion. 2011 Oct;51(10):2189-98. doi: 10.1111/j.1537-2995.2011.0311.x.
Nguyen-Dumont T, Jordheim LP, Michelon J, Forey N, McKay-Chopin S, Sinilnikova O, Le Calvez-Kelm F, Southey MC, Tavtigian SV, Lesueur F. Detecting differential allelic expression using high-resolution melting curve analysis: application to the breast cancer susceptibility gene CHEK2. 2011 BMC Medical Genomics May;4:39.
Kote-Jarai Z, Amin Al Olama A, Leongamornlert D, Tymrakiewicz M, Saunders E, Guy M, Giles GG, Severi G, Southey M, Hopper JL et al. Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript. Human Genetics. 2011 Jun;129(6):687-694.
Parry S, Win AK, Parry B, Macrae FA, Gurrin LC, Church JM, Baron JA, Giles GG, Leggett BA, Winship I et al. Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut. 2011 Jul;60(7):950-957.
Lin SJ, Cawson J, Hill P, Haviv I, Jenkins M, Hopper JL, Southey MC, Campbell IG, Thompson EW. Image-guided sampling reveals increased stroma and lower glandular complexity in mammographically dense breast tissue. Breast Cancer Research and Treatment. 2011 Jul;128(2):505-516.
Goldgar DE, Healey S, Dowty JG, Da Silva L, Chen X, Spurdle AB, Terry MB, Daly MJ, Buys SM, Southey MC et al. Rare variants in the ATM gene and risk of breast cancer. Breast Cancer Research. 2011 Jul 13(4):R73.
Lin WY, Camp NJ, Cannon-Albright LA, Allen-Brady K, Balasubramanian S, Reed MW, Hopper JL, Apicella C, Giles GG, Southey MC et al. A role for XRCC2 gene polymorphisms in breast cancer risk and survival. Journal of Medical Genetics. 2011 Jul;48(7):477-484.
Broeks A, Schmidt MK, Sherman ME, Couch FJ, Hopper JL, Dite GS, Apicella C, Smith LD, Hammet F, Southey MC et al. Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Human Molecular Genetics. 2011 Aug 15;20(16):3289-3303.
Kote-Jarai Z, Olama AA, Giles GG, Severi G, Schleutker J, Weischer M, Campa D, Riboli E, Key T, Gronberg H et al. Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nature Genetics. 2011 Aug;43(8):785-791.
Feng BJ, Tavtigian SV, Southey MC, Goldgar DE. Design considerations for massively parallel sequencing studies of complex human disease. PloS One. 2011 Aug 6(8).
Bertalli NA, Allen KJ, McLaren CE, Turkovic L, Osborne NJ, Constantine CC, Delatycki MB, English DR, Giles GG, Hopper JL et al. A comparison of self-reported and record-linked blood donation history in an Australian cohort. Transfusion. 2011 Oct;51(10):2189-98.
Milne RL, Goode EL, Garcia-Closas M, Couch FJ, Severi G, Hein R, Fredericksen Z, Malats N, Zamora MP, Arias Perez JI et al. Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer. Cancer Epidemiology, Biomarkers and Prevention. 2011 Oct;20(10):2222-2231.
Milne RL, John EM, Knight JA, Dite GS, Southey MC, Giles GG, Apicella C, West DW, Andrulis IL, Whittemore AS et al. The potential value of sibling controls compared with population controls for association studies of lifestyle-related risk factors: an example from the Breast Cancer Family Registry. International Journal of Epidemiology. 2011 Oct;40(5):1342-1354.
Milne RL, Lorenzo-Bermejo J, Burwinkel B, Malats N, Arias JI, Zamora MP, Benitez J, Humphreys MK, Garcia-Closas M, Chanock SJ et al. 7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium. Journal of Medical Genetics. 2011 Oct;48(10):698-702.
Peterlongo P, Caleca L, Cattaneo E, Ravagnani F, Bianchi T, Galastri L, Bernard L, Ficarazzi F, Dall'olio V, Marme F, Langheinz A et al. The rs12975333 variant in the miR-125a and breast cancer risk in Germany, Italy, Australia and Spain. Journal of Medical Genetics. 2011 Oct;48(10):703-704.
Win AK, Cleary SP, Dowty JG, Baron JA, Young JP, Buchanan DD, Southey MC, Burnett T, Parfrey PS, Green RC et al. Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer. International Journal of Cancer. 2011 Nov 1;129(9):2256-62
Maxwell CA, Benitez J, Gomez-Baldo L, Osorio A, Bonifaci N, Fernandez-Ramires R, Costes SV, Guino E, Chen H, Evans GJ et al. Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. PLoS Biology. 2011 Nov;9(11):e1001199.
Mulligan AM, Couch FJ, Barrowdale D, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Robson M, Sherman M, Spurdle AB et al. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Research. 2011 Nov 13(6):R110.
Im KM, Kirchhoff T, Wang X, Green T, Chow CY, Vijai J, Korn J, Gaudet MM, Fredericksen Z, Shane Pankratz V et al. Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. Human Genetics. 2011 Nov;130(5):685-699.
Cox DG, Simard J, Sinnett D, Hamdi Y, Soucy P, Ouimet M, Barjhoux L, Verny-Pierre C, McGuffog L, Healey S et al. Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers. Human Molecular Genetics. 2011 Dec 1;20(23):4732-4747.
Haiman CA, Chen GK, Vachon CM, Canzian F, Dunning A, Millikan RC, Wang X, Ademuyiwa F, Ahmed S, Ambrosone CB et al. A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nature Genetics. 2011 Dec;43(12):1210-1214.
Figueroa JD, Garcia-Closas M, Humphreys M, Platte R, Hopper JL, Southey MC, Apicella C, Hammet F, Schmidt MK, Broeks A et al. Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Human Molecular Genetics. 2011 Dec 1;20(23):4693-4706.
Greenwood CM, Paterson AD, Linton L, Andrulis IL, Apicella C, Dimitromanolakis A, Kriukov V, Martin LJ, Salleh A, Samiltchuk E et al. A genome-wide linkage study of mammographic density, a risk factor for breast cancer. Breast Cancer Research. 2011 Dec 13(6):R132.
Stevens KN, Garcia-Closas M, Fredericksen Z, Kosel M, Pankratz VS, Hopper JL, Dite GS, Apicella C, Southey MC, Schmidt MK et al. Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk. British Journal of Cancer. 2011 Dec 6;105(12):1934-1939.
Park DJ, Odefrey FA, Hammet F, Giles GG, Baglietto L, ABCFS, MCCS, Hopper JL, Schmidt DF, Makalic E et al. FAN1 variants identified in multiple-case early-onset breast cancer families via exome sequencing: no evidence for association with risk for breast cancer. Breast Cancer Research and Treatment. 2011 Dec;130(3):1043-1049.
Kurian AW, Gong GD, John EM, Johnston DA, Felberg A, West DW, Miron A, Andrulis IL, Hopper JL, Knight JA et al. Breast cancer risk for noncarriers of family-specific BRCA1 and BRCA2 mutations: findings from the Breast Cancer Family Registry. Journal of Clinical Oncology. 2011 Dec 1;29(34):4505-4509.
Wong EM, Dobrovic A. Assessing gene-specific methylation using HRM-based analysis. Methods in Molecular Biology 687:207-17 (2011).